StockData
Oncolytics Biotech Inc logo

Oncolytics Biotech Inc (ONCY) stock

ONCYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 10-Q on Nov 13, 2026Score 0/30
$0.38+0.04 (+12.53%)

Close on Nov 17, 2026Market cap $48.77MP/E –Yield –

Oncolytics Biotech ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

For fiscal 2024 it was -C$34.86M. The highest annual figure on record is -C$13.74M in fiscal 2015.

Annual ebitda

PeriodPeriod endValueChange
FY2024Dec 31, 2024-C$34.86M–
FY2023Dec 31, 2023-C$33.71M–
FY2022Dec 31, 2022-C$26.83M–
FY2021Dec 31, 2021-C$26.11M–
FY2020Dec 31, 2020-C$25.37M–
FY2019Dec 31, 2019-C$20.25M–
FY2018Dec 31, 2018-C$17.18M–
FY2017Dec 31, 2017-C$15.51M–
FY2016Dec 31, 2016-C$15.13M–
FY2015Dec 31, 2015-C$13.74M–

More Oncolytics Biotech figures

See a number that looks wrong?